Form 4 for SBC SBC Medical Group Holdings Inc
Accepted 2026-04-29 21:38:46 ET · period of report 2026-04-28 · accession 0001493152-26-019703 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 21:38 | 2026-04-28 | SBC | Aikawa Yoshiyuki | COB, CEO, Dir, 10% | S - Sale | $3.02 | -465.0K | 78.84M | -0.6% | -$1.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-28 | S | D | 465,000 | $3.02 | 78,839,460 | D | — | — | (F1) The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated ("SBC shares"), which were sold by the Reporting Person, on the closing date of April 28, 2026, pursuant to the underwriters' option to purchase additional shares in connection with an underwritten public offering that initially closed on April 21, 2026. |